Disc Medicine Inc. (IRON)
NASDAQ: IRON
· Real-Time Price · USD
51.94
-1.77 (-3.30%)
At close: Jun 16, 2025, 3:59 PM
-3.30% (1D)
| Bid | 49.53 |
| Market Cap | 1.8B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -116.49M |
| EPS (ttm) | -3.89 |
| PE Ratio (ttm) | -13.35 |
| Forward PE | -10 |
| Analyst | Buy |
| Ask | 55.3 |
| Volume | 340,279 |
| Avg. Volume (20D) | 442,833 |
| Open | 53.85 |
| Previous Close | 53.71 |
| Day's Range | 51.28 - 53.53 |
| 52-Week Range | 30.82 - 68.73 |
| Beta | 2.50 |
About IRON
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IRON
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IRON stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+11.21%
Disk Medicine shares are trading higher. HC Wainwr...
Unlock content with
Pro Subscription
7 months ago
+23.59%
Disc Medicine shares are trading higher after the company announced the end of its Phase 2 Bitopertin In Erythropoietic Protoporphyria meeting with the FDA. The company is aligned with the FDA across all proposed study parameters and has a clear development path to registration.
